Входя на эту страницу, Вы подтверждаете, что являетесь  медицинским работником.

Status message

Not the entire site translated, but only to "Magazine"

Algorithm for the biological treatment of acute episode of recurrent depressive disorder

S.N. Mosolov, E.G. Kostyukova, M.Ya. Ladyzhensky

Summary

This publication provides algorithm for biological treatment of Recurrent Depressive Disorder (RDR). Algorithm is presented in the form of schemes of step-by-step selection of therapeutic interventions depending on the degree of evidences of their effectiveness in randomized controlled studies. The treatment tolerability were assessed as well, and level of recommendation of the intervention was also indicated. Data from Russian and foreign literature (systematic reviews, meta-analyses) and contemporary clinical recommendations of international expert groups. Algorithm is provided with text explanations and step-by-step comments. The sources of the extent evidences and the literature recommended for additional information are also provided.

Contact: profmosolov@mtu-net.ru

References: 
  • 1. Avrutskii G.Ya., Mosolov S.N., Sharov A.I. Sravnitel'naya effektivnost' timoanalepticheskoi terapii depressivnykh i depressivno-bredovykh sostoyanii pri faznoprotekayushchikh psikhozakh // Sotsial'naya i klinicheskaya psikhiatriya. − 1991. − № 1. − S. 84−91.
  • 2. Avrutskii G.Ya., Neduva A.A. Lechenie psikhicheskikh bol'nykh: Rukovodstvo dlya vrachei. − M.: Meditsina, 1981. – S. 172−176.
  • 3. Avrutskii G.Ya., Neduva A.A., Moshchevitin S.Yu. i dr. Primenenie elektrosudorozhnoi terapii (EST) v psikhiatricheskoi praktike: metodich. rekomendatsii. − M., 1989. – 42 s.
  • 4. Arana D., Rozenbaum D. Farmakoterapiya psikhicheskikh rasstroistv / pod red. S.N. Mosolova. – M., 2004.
  • 5. Alfimov P.V., Kostyukova E.G., Mosolov S.N. Sovremennye metody preodoleniya terapevticheskoi rezistentnosti pri rekurrentnoi depressii // Biologicheskie metody terapii psikhicheskikh rasstroistv (dokazatel'naya meditsina – klinicheskoi praktike). – M.: Sotsial'no-politicheskaya mysl', 2012. − S. 438−473.
  • 6. Vernekina N.S., Kartelishev A.V., Igel'nik M.V. Lazeroterapiya v kompleksnom lechenii psikhicheski bol'nykh // Sotsial'naya i klinicheskaya psikhiatriya. − 1994. − № 4. − S. 125−130.
  • 7. Vovin R.Ya., Aksenova I.O. Zatyazhnye depressivnye sostoyaniya. − L., Meditsina, 1982. − 191 s.
  • 8. Il'in S.A., Tsukarzi E.E., Mosolov S.N. Sravnitel'naya effektivnost' i perenosimost' tsiklicheskoi transkranial'noi magnitnoi stimulyatsii i elektrosudorozhnoi terapii pri zatyazhnykh, terapevticheski rezistentnykh depressiyakh //Sotsial'naya i klinicheskaya psikhiatriya. − 2008. − № 2. − S. 73−80.
  • 9. Karimulaev I.A., Kalinin V.V., Mosolov S.N. Primenenie metoda adaptatsii k periodicheskoi normobaricheskoi gipoksii v lechenii farmakorezistentnykh depressii // Novye dostizheniya v terapii psikhicheskikh zabolevanii / pod. red. S.N. Mosolova. − M., 2002. − S. 579−592.
  • 10. Kekelidze Z.I., Tvaladze M.G., Chechelashvili A.P., Chkheidze M.A. Rol' i mesto infuzii obluchennoi ul'trafioletom autokrovi v lechenii depressivnykh sostoyanii // Sotsial'naya i klinicheskaya psikhiatriya. – 1993. − № 3. − S. 88−94.
  • 11. Mazo G.E. Terapevticheski rezistentnye depressii: podkhody k terapii // Sotsial'naya i klinicheskaya psikhiatriya. − 2004. − № 4 (14). − S. 59−65.
  • 12. Mazo G.E., Neznanov N.G. Terapevticheski rezistentnye depressii. − SPb., 2012. − 448 s.
  • 13. Malin D.I. Plazmaferez v psikhiatrii i narkologii. − M.: Sputnik, 1997. − 143 s.
  • 14. Malin D.I., Kostitsyn N.V. Plazmaferez v sochetanii s odnomomentnoi otmenoi psikhotropnykh sredstv v lechenii rezistentnykh depressivnykh sostoyanii u bol'nykh s endogennymi psikhozami // Sotsial'naya i klinicheskaya psikhiatriya. – 1993. − № 3. − S. 95−99.
  • 15. Mezhdunarodnaya klassifikatsiya boleznei. Klassifikatsiya psikhicheskikh i povedencheskikh rasstroistv. 10-i peresmotr // VOZ. – SPb.: ADIS, 1994. – 303 s.
  • 16. Mosolov S.N. Klinicheskoe primenenie sovremennykh antidepressantov // Meditsinskoe informatsionnoe agentstvo. – SPb., 1995. – 566 s.
  • 17. Mosolov S.N., Kostyukova E.G., Serditov O.V. Cerotoninovyi sindrom pri lechenii depressii // Mezhdunarodnyi zhurnal meditsinskoi praktiki. − 2000. − № 8. − S. 28−33.
  • 18. Mosolov S.N. Novye dostizheniya v terapii psikhicheskikh zabolevanii. – M.: Binom, 2002. – 622 s.
  • 19. Mosolov S.N. Rezistentnost' k psikhofarmakoterapii i metody ee preodoleniya // Psikhiatriya i psikhofarmakoterapiya. − 2004. − № 2. − S. 128−132.
  • 20. Mosolov S.N. Sovremennye biologicheskie gipotezy rekurrentnoi depressii (obzor) // Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. − 2012. − T. 112, № 11-2. − S. 29−40.
  • 21. Mosolov S.N. Biologicheskie metody terapii psikhicheskikh rasstroistv (dokazatel'naya meditsina – klinicheskoi praktike). – M.: Sotsial'no-politicheskaya mysl', 2012. – 1080 s.
  • 22. Mosolov S.N., Kostyukova E.G Aktual'nye voprosy farmakoterapii depressii. V knige: Novye dostizheniya v terapii psikhicheskikh zabolevanii / pod red. S.N. Mosolova. − M., 2002. − S. 211−231.
  • 23. Mosolov S.N., Misionzhnik E.Yu., Tsukarzi E.E. i dr. Primenenie dofaminstimuliruyushchei terapii u rezistentnykh k antidepressantam bol'nykh endogennymi depressiyami // Sotsial'naya i klinicheskaya psikhiatriya. − 1995. − T. 3, № 4. − S. 76−81.
  • 24. Mosolov S.N., Uzbekov M.G., Saikin M.A., Tsukarzi E.E. i soavt. Primenenie vnutrivennoi nizkointensivnoi gelii-neonovoi lazeroterapii i izmenenie ryada biokhimicheskikh parametrov u rezistentnykh k psikhofarmakoterapii bol'nykh shizofreniei // Sotsial'naya i klinicheskaya psikhiatriya. − 1999. − T. 9, № 2. − S. 57−62.
  • 25. Nel'son A.I. Elektrosudorozhnaya terapiya v psikhiatrii, narkologii i nevrologii. − M.: BINOM. Laboratoriya znanii, 2005. − 368 s.
  • 26. Nikolaev Yu.S., Polishchuk Yu.I., Zairov G.K., Neznamov G.G. Razgruzochno-dieticheskaya terapiya nervno-psikhicheskikh zabolevanii: metodich. rekomendatsii. − M., 1979.
  • 27. Nuller Yu.L., Mikhalenko I.N. Affektivnye psikhozy. − L.: Meditsina, 1988. − 329 s.
  • 28. Podkorytov B.C., Chaika Yu.Yu. Depressii. Sovremennaya terapiya: rukovodstvo dlya vrachei. − Khar'kov: Tornado, 2003. − 352 s.
  • 29. Portnov F.G. Elektropunkturnaya refleksoterapiya. − Riga, 1980. − 217 s.
  • 30. Psikhofarmakologicheskie i protivoepilepticheskie preparaty, razreshennye k primeneniyu v Rossii. – Izd. 2-e, ispr. i pererab.; pod red. S.N. Mosolova. – M., 2004.
  • 31. Prokhorova I.S. Nekotorye teoreticheskie i prakticheskie aspekty primeneniya odnomomentnoi otmeny psikhotropnykh sredstv. Avtoref. diss. ... kand. med. nauk. − M., 1975. − 22 s.
  • 32. Pugovkina O.D., Kholmogorova A.B., Tsukarzi E. E. i dr. Dinamika kognitivnykh funktsii u patsientov s rezistentnymi depressiyami pri primenenii elektrosudorozhnoi terapii i transkranial'noi magnitnoi stimulyatsii // Sotsial'naya i klinicheskaya psikhiatriya. − 2006. − № 2 (16). − S. 47−51.
  • 33. Saikin M.A., Mosolov S.N., Kapiletti S.G., Tsukarzi E.E., Ostrovskii I.P. Effektivnost' vnutrivennogo gelii-neonovogo lazernogo oblucheniya krovi u bol'nykh endogennymi depressiyami, rezistentnymi k psikhofarmakoterapii // Panteleeva G.P., Tsutsul'kovskaya M.Ya. Affektivnye i shizoaffektivnye psikhozy: Materialy nauch.-prakt. konf. s mezhdunar. uchastiem. 7−8 aprelya 1998 g.
  • 34. Simutkin G.G. Nelekarstvennye metody khronobiologicheskoi terapii affektivnykh rasstroistv // Khronobiologicheskaya teoriya affektivnykh rasstroistv / pod red. S.N. Mosolova. − M.: Avanport, 2014. − S. 164−217.
  • 35. Terenkovskii D.I. Razgruzochno-dieticheskaya terapiya v sochetanii s psikhoterapiei ipokhondricheskikh sostoyanii psikhogennogo geneza. Avtoref. diss. ... kand. med. nauk. M., 1982. − 18 s.
  • 36. Khronobiologicheskaya teoriya affektivnykh rasstroistv / pod red. S.N. Mosolova. − M.: Avanport, 2014. − 352 s.
  • 37. Tsukarzi E.E., Il'in S.A., Mosolov S.N. Primenenie transkranial'noi magnitnoi stimulyatsii i elektrosudorozhnoi terapii pri terapevticheski rezistentnykh depressiyakh // Sovremennaya terapiya psikhicheskikh zabolevanii. – 2015. − № 4. − S. 25−33.
  • 38. Adli M., Rush A.J., Moller H.J., Bauer M. Algorithms for optimizing the treatment of depression: making the right decision at the right time // Pharmacopsychiatry. − 2003. − Vol. 36, Suppl. 3. − P. 222−229.
  • 39. Angst J. The course of affective disorders // Psychopathology. − 1986. − Vol. 19, Suppl. 2. − P. 47−52.
  • 40. APA. Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association // Am J Psychiatry. − 2000. − Vol. 157, Suppl. 4. − P. 1−45.
  • 41. APA. Practice guideline for the Treatment of Patients with Major Depressive Disorder. − American Psychiatric Association. 2010.
  • 42. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition (DSM-5). – Arlington, VA: American Psychiatric Publishing, 2013.
  • 43. Anderson I.M., Nutt D.J., Deakin J.F. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology // J Psychopharmacol. − 2000. − Vol. 14, No 1. − P. 3−20.
  • 44. Anderson I.M. Meta-analytical studies on new antidepressants // Br Med Bull. − 2001. − Vol. 57. − P. 161−178.
  • 45. Aronson R., Offman H.J., Joffe R.T. et al. Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis // Arch Gen Psychiatry. − 1996. − Vol. 53 (9). − P. 842−848.
  • 46. Baghai T.C., Blier P., Baldwin D.S. et al. General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry // Eur Arch Psychiatry Clin Neurosci. − 2011. − Vol. 261, Suppl. 3. − P. 207−245.
  • 47. Ballesteros J., Callado L. F. Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomised controlled trials // J Affect Disord. − 2004. − Vol. 79 (1-3). − P. 137−147.
  • 48. Bauer M., Dopfmer S. Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies // J Clin Psychopharmacol. − 1999. − Vol. 19 (5). − P. 427−434.
  • 49. Bauer M., Baur H., Berghofer A., Strohle A. et al. Effects of supraphysiological thyroxine administration in healthy controls and patients with depressive disorders // J Affect Disord. − 2002. − Vol. 68, No 2−3. − P. 285−294.
  • 50. Bauer M., Pfennig A., Linden M. et al. Efficacy of an algorithm-guided treatment compared with treatment as usual: a randomized, controlled study of inpatients with depression // J Clin Psychopharmacol. − 2009. − Vol 29, No 4. − P. 327−333.
  • 51. Bauer M., Whybrow P.C., Angst J. et al. World federation of societies of biological psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorder. Part 1: Acute and Continuation Treatment of Major Depressive Disorder // The World Journal of Biological Psychiatry: the Official Journal of the World Federation of Societies of Biological Psychiatry. − 2002. − No 3. − P. 4−89.
  • 52. Bauer M., Whybrow P.C., Angst J. et al. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions // World J Biol Psychiatry. − 2002. − Vol. 3, No 2. − P. 69−86.
  • 53. Bauer M., Pfennig A., Severus E. et al. World Federation of Societies of Biological Psychiatry ( WFSBP) Guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders // World J Biol Psychiatry. − 2013. − Vol. 14, No 5. − P. 334−385.
  • 54. Bersani F.S., Minichino A., Enticott P.G. et al. Deep transcranial magnetic stimulation as a treatment for psychiatric disorders: a comprehensive review // Eu. Psychiatry. − 2013. − Vol. 28 (1). − P. 30–9.
  • 55. Bretlau L.G., Lunde M., Lindberg L. et al. Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial // Pharmacopsychiatry. − 2008. Vol. 41, No 2. − P. 41−47.
  • 56. Bschor T., Baethge C. No evidence for switching the antidepressant: systematic review and meta-analysis of RCTs of a common therapeutic strategy // Acta Psychiatr Scand. − 2010. − Vol. 121, No 3. − P. 174−179.
  • 57. CANMAT. Clinical guidelines for the treatment of depressive disorders // Can J Psychiatry. − 2001. − Vol. 46, Suppl. 1. − P. 5S−90S.
  • 58. CANMAT. Canadian Network for Mood and Anxiety Treatments (CANMAT). Clinical guidelines for the management of major depressive disorder in adults, 2009.
  • 59. Carpenter L.L., Yasmin S., Price L.H. A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine // Biol Psychiatry. − 2002. − Vol. 51 (2). − P. 183−188.
  • 60. Cipriani A., Furukawa T.A., Salanti G. et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis // Lancet. − 2009. − Vol. 373, No 9665. − P. 746−758.
  • 61. Conca A., Koppi S., Konig P. et al. Transcranial magnetic stimulation: a novel antidepressive strategy? // Neuropsychobiology. − 1996. − Vol. 34. − P. 204−207.
  • 62. Connolly KR, Thase ME If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies // Drugs. − 2011. − Vol. 71, No 1. − P. 43−64.
  • 63. Cowen P.J. Pharmacological management of treatment-resistant depression // Advances in Psychiatric Treatment. − 1998. − Vol. 4. − P. 320−327.
  • 64. Cowen P.J. New drugs, old problems // Advances in Psychiatric Treatment. − 2005. − Vol. 11. − P. 19−27.
  • 65. Crossley N.A., Bauer M. Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebo-controlled trials // J Clin Psychiatry. − 2007. − Vol. 68 (6). − P. 935−940.
  • 66. Daban C., Martinez-Aran A., Cruz N., Vieta E. Safety and efficacy of Vagus Nerve Stimulation in treatment-resistant depression. A systematic review // J Affect Disord. − 2008. − Vol. 110, No 1−2. P. 1−15.
  • 67. Danish University Antidepressant Group. Clomipramine dose-effect study in patients with depression: clinical end points and pharmacokinetics. Danish University Antidepressant Group (DUAG) // Clin Pharmacol Ther. − 1999. − Vol. 66, No 2. − P. 152−165.
  • 68. DeBattista C., Solvason H.B., Poirier J. et al. A prospective trial of bupropion SR augmentation of partial and non-responders to serotonergic antidepressants // J Clin Psychopharmacol. − 2003. − Vol. 23, No 1. − P. 27−30.
  • 69. De Jonghe F., Hendricksen M., Van A.G. et al. Psychotherapy alone and combined with pharmacotherapy in the treatment of depression // Br J Psychiatry. − 2004. − Vol. 185.− P. 37−45.
  • 70. DGPPN, BÄK, KBV für die Leitliniengruppe Unipolare Depression. S3-Leitlinie / Nationale VersorgungsLeitlinie Unipolare Depression − Langfassung. − Berlin, Düsseldorf: DGPPN, ÄZQ, AWMF, 2009.
  • 71. Di Lazzaro V., Ziemann U., Lemon R.N. State of the art: Physiology of transcranial motor cortex stimulation // Brain Stimulation: Basic, Translational and Clinical Research in Neuromodulation. − 2008. − Vol. 1, No 4. − P. 345−362.
  • 72. Dombrovski A.Y., Mulsant B.H., Haskett R.F. et al. Predictors of remission after electroconvulsive therapy in unipolar major depression // J Clin Psychiatry. − 2005. − Vol. 66, No 8. − P. 1043−1049.
  • 73. Dudek D., Rybakowski J.K., Siwek M. et al. Risk factors of treatment resistance in major depression: association with bipolarity // J Affect Disord. − 2010. − Vol. 126, No 1-2. − P. 268−271.
  • 74. Ernst E. Is reflexology an effective intervention? A systematic review of randomised controlled trials // Med J Aust. – 2009. − Vol. 191 (5). − P. 263–266.
  • 75. Farahani A., Correll C.U. Are antipsychotics or antidepressants needed for psychotic depression? A systematic review and meta-analysis of trials comparing antidepressant or antipsychotic monotherapy with combination treatment // J Clin Psychiatry. − 2012. − Vol. 73, No 4. − P. 486−496.
  • 76. Fava M., Rush A.J., Trivedi M.H. et al. Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study // Psychiatr Clin North Am. − 2003. − Vol. 26, No 2. − P. 457−494.
  • 77. Ferreri M., Lavergne F., Berlin I. et al. Benefits from mianserin augmentation of fluoxetine in patients with major depression non-responders to fluoxetine alone // Acta Psychiatr Scand. − 2001. − Vol. 103, No 1. − P. 66−72.
  • 78. Finfgeld D.L. Serotonin syndrome and the use of SSRIs // J Psychosoc Nurs Ment Health Serv. − 2004. − ol. 42, No 2. − P. 16−20.
  • 79. Fink M. Convulsive therapy: a review of the first 55 years // J Affect Disord. − 2001. Vol. 63, No 1-3. − P. 1−15.
  • 80. Frank E., Thase M.E., Spanier C. et al. Psychotherapy of affective disorders / Helmchen H., Henn F., Lauter H., Sartorius N. eds. // Contemporary Psychiatry. − Heidelberg: Springer, 2000. − P. 348−363.
  • 81. Furukawa T.A., Streiner D.L., Young L.T. Antidepressant plus benzodiazepine for major depression // Cochrane Database Syst Rev. − 2001. − Vol. 2. − CD001026.
  • 82. Gaynes B.N., Warden D., Trivedi M.H. et al. What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression // Psychiatr Serv. − 2009. − Vol. 60, No. 11. − P. 1439−1445.
  • 83. Geddes J.R., Carney S.M., Davies C., Furukawa T.A., Kupfer D.J., Frank E. et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review // Lancet 361. − 2003. − Vol. 9358. − P. 653−661.
  • 84. George M.S., Rush A.J., Marangell L.B. et al. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression // Biol Psychiatry. − 2005. − Vol. 58 (5). − P. 364−373.
  • 85. Giacobbe P., Kennedy S.H. Deep brain stimulation for treatment-resistant depression: a psychiatric perspective // Curr Psychiatry Rep. − 2006. − Vol. 8 (6). − P. 437−444.
  • 86. Giedke H., Klingberg S., Schwarzler F., Schweinsberg M. Direct comparison of total sleep deprivation and late partial sleep deprivation in the treatment of major depression // J Affect Disord. − 2003. − Vol. 76, No 1-3. − P. 85−93.
  • 87. Greenberg B.D., Gabriels L.A., Malone D.A. et al. Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience // Mol Psychiatry. − 2008. − May, 20.
  • 88. Grunze H., Vieta E., Goodwin G.M. et al. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression // World J Biol Psychiatry. − 2010. − Vol. 11, No 2. − P. 81−109.
  • 89. Hamilton M. A rating scale for depression // J Neurol Neurosurg Psychiatry. − 1960. − Vol. 23. − P. 56−62.
  • 90. Herrmann L.L., Ebmeier K.P. Factors modifying the efficacy of transcranial magnetic stimulation in the treatment of depression: a review // J Clin Psychiatry. − 2006, Dec. − Vol. 67, No 12. − P. 1870−1876.
  • 91. Higgins E.S., George M.S. Brain Stimulation Therapies for Clinicians. − Washington: American Psychiatric Press, 2008.
  • 92. Jindal R.D., Thase M.E. Integrating psychotherapy and pharmacotherapy to improve outcomes among patients with mood disorders // Psychiatr Serv. − 2003. − Vol. 54, No 11. − P. 1484−1490.
  • 93. Kennedy S.H., Lam R.W., Cohen N.L., Ravindran A.V. Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments // Can J Psychiatry. − 2001. − Vol. 46, Suppl. 1. − P. 38−58.
  • 94. Komossa K., Depping A.M., Gaudchau A. et al. Second-generation antipsychotics for major depressive disorder and dysthymia // Cochrane Database Syst Rev. − 2010. − Vol. 12. − CD008121.
  • 95. Kozel F.A., George M.S. Meta-analysis of left prefrontal repetitive transcranial magnetic stimulation (rTMS) to treat depression // J Psychiatr Pract. − 2002. − Vol. 8 (5). − P. 270−275.
  • 96. Kopell B.H., Greenberg B., Rezai A.R. Deep brain stimulation for psychiatric disorders // J Clin Neurophysiol. − 2004. − Vol. 21. − P. 51−67.
  • 97. Kunzel H.E., Ackl N., Hatzinger M. et al. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol − a double-blind multicenter trial // J Psychiatr Res. − 2009. − Vol. 43, No 7. − P. 702−710.
  • 98. Kupfer D.J. Management of recurrent depression // J Clin Psychiatry. − 1993. − Vol. 54, Suppl. − P. 29−33.
  • 99. Linde K., Berner M.M., Kriston L. St John's wort for major depression // Cochrane Database Syst Rev. − 2008. − Vol. 4. − CD000448.
  • 100. Loo C.K., McFarquhar T.F., Mitchell P.B. A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression // Int J Neuropsychopharmacol. − 2008. − Vol. 11, No 1. − P. 131−147.
  • 101. Lozano A.M., Mayberg H.S., Giacobbe P. et al. Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression // Biological Psychiatry. − 2008, Sept. 15. − Vol. 64, No 6. − P. 461−467.
  • 102. Malhi G.S., Adams D, Porter R, et al. Clinical practice recommendations for depression // Acta Psychiatr Scand. − 2009. − Vol. 439, Suppl. − P. 8−26.
  • 103. Malhi G.S., Bassett D., Boyce P. et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders // Australian & New Zealand Journal of Psychiatry. − 2015. − Vol. 49 (12). − P. 1087–1206. − DOI: 10.1177/0004867415617657.
  • 104. Mann J.J. The medical management of depression // N Engl J Med. − 2005. − Vol. 353, No 17. − P. 1819−1834.
  • 105. Martin J.L., Barbanoj M.J., Schlaepfer T.E. et al. Repetitive transcranial magnetic stimulation for the treatment of depression. Systematic review and meta-analysis // Br J Psychiatry. − 2003. − Vol. 182. − P. 480−491
  • .
  • 106. Mead G.E., Morley W., Campbell P. et al. Exercise for depression // Cochrane Database Syst Rev. − 2008. −Vol. 4. − CD004366.
  • 107. Montgomery S.A., Asberg M. 1979. A new depression scale designed to be sensitive to change // Br J Psychiatry. − 2005. − Vol. 134. − P. 382−389.
  • 108. Mosimann U.P., Schmitt W., Kosel M. et al. Repetitive Transcranial Magnetic Stimulation (rTMS) as a Putative Treatment for Major Depression – A Sham Controlled Study in Relatively Older Patients // Psychiatry Research. − 2004. − Vol. 126, No 2. − P. 123−133.
  • 109. Mosolov S., Ushkalova A., Kostukova E. et al. Bipolar II disorder in patients with a current diagnosis of recurrent depression // Bipolar Disorders. − 2014. − Vol. 16, No 4. − P. 389−399.
  • 110. Nahas Z., Teneback C., Chae J.H. et al. Serial vagus nerve stimulation functional MRI in treatment-resistant depression // Neuropsychopharmacology. − 2007. − Vol. 32, No 8. − P. 1649−1660.
  • 111. Nemets B., Stahl Z., Belmaker R. H. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder // Am J Psychiatry. − 2002. − Vol. 159 (3). − P. 477−479.
  • 112. Nierenberg A.A., Alpert J.E., Gardner-Schuster E.E. et al. Vagus nerve stimulation: 2-year outcomes for bipolar versus unipolar treatment-resistant depression // Biol Psychiatry. − 2008. − Vol. 64, No 6. − P. 455−460.
  • 113. Nierenberg A.A., Fava M., Trivedi M.H. et al. A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report // Am J Psychiatry. − 2006. − Vol. 163, No 9. − P. 1519−1530.
  • 114. Nelson J.C. Treatment of antidepressant nonresponders: augmentation or switch? // J Clin Psychiatry. − 1998. − Vol. 59, Suppl. 15.− P. 35−41.
  • 115. NICE. The treatment and management of depression in adults (updated edition). − The British Psychological Society and The Royal College of Psychiatrists, 2009. − 85 p.
  • 116. Pagnin D., Pini S., Cassano G.B. Efficacy of ECT in depression: a meta-analytic review // JECT. − 2004. − Vol. 20, No 1. − P. 13−20.
  • 117. Papakostas G.I., Shelton R.C., Smith J. et al. Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis // J Clin Psychiatry. − 2007. − Vol. 68 (6). − P. 826−831.
  • 118. Papakostas G.I., Fava M., Thase M.E. Treatment of SSRI-resistant depression: a meta-analysis comparing within- versus across-class switches // Biol Psychiatry. 2008. − Vol. 63 (7). − P. 699−704.
  • 119. Patkar A.A., Masand P.S., Pae C.U. et al. A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression // J Clin Psychopharmacol. − 2006. − Vol. 26 (6). − P. 653−656.
  • 120. Peet M., Horrobin D.F. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs // Arch Gen Psychiatry. − 2002. − Vol. 59 (10). − P. 913−919.
  • 121. Perry P.J. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants // J Affect Disord. − 1996. − Vol. 39, No 1. − P. 1−6.
  • 122. Poulet E., Brunelin J., Boeuve C. et al. Repetitive transcranial magnetic stimulation does not potentiate antidepressant treatment // Eur Psychiatry. − 2004.− Vol. 19, No 6. − P. 382−383.
  • 123. Portella MJ, de Diego-Adelino J, Ballesteros J et al. Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression// J Clin Psychiatry. – 2011. – No 72. – P. 962–969.
  • 124. Prudic J., Olfson M., Marcus S.C. et al. Effectiveness of electroconvulsive therapy in community settings // Biol Psychiatry. − 2004. − Vol. 55, No 3. − P. 301−312.
  • 125. Rasmussen K.G., Mueller M., Knapp R.G. et al. Antidepressant medication treatment failure does not predict lower remission with ECT for major depressive disorder: a report from the consortium for research in electroconvulsive therapy // J Clin Psychiatry. − 2007. − Vol. 68, No 11. − P.1701−1706.
  • 126. Ravindran A.V., Kennedy S.H., O'Donovan M.C. et al. Osmotic-release oral system methylphenidate augmentation of antidepressant monotherapy in major depressive disorder: results of a double-blind, randomized, placebo-controlled trial // J Clin Psychiatry. − 2008. − Vol. 69 (1). − P.87−94.
  • 127. Ricken R., Wiethoff K., Reinhold T., Schietsch K., Stamm T., Kiermeir J. et al. Algorithm-guided treatment of depression reduces treatment costs − results from the randomized controlled German Algorithm Project (GAPII) // J Affect Disord. − 2011. − Vol. 134, No 1-3. − P. 249−256.
  • 128. Rosa M.A., Lisanby S.H. Somatic treatments pharmaceutical design // Neuropsychopharmacology. – 2012. –No 37. – P. 102–116
  • 129. Rossini D., Lucca A., Zanardi R. et al. Transcranial magnetic stimulation in treatment-resistant depressed patients: a double-blind, placebo-controlled trial // Psychiatry Res. − 2005. − Vol. 137, No 1-2. − P. 1−10.
  • 130. Rumi D.O., Gattaz W.F., Rigonatti S.P. et al. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study // Biol Psychiatry. − 2005. − Vol. 57, No 2. − P. 162−166.
  • 131. Rush A.J., Fava M., Wisniewski S.R., Lavori P.W., Trivedi M.H., Sackeim H.A. et al. Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design // Control Clin.Trials. − 2004. − Vol. 25, No 1. − P. 119−142.
  • 132. Rush A.J., Kupfer D.J. Strategies and tactics in the treatment of depression // Gabbard G.O., ed. Treatment of Psychiatric Disorders. − Washington, DC: American Psychiatric Publishing, Inc., 2001. − P. 1417−1439.
  • 133. Rush A.J., Sackeim H.A., Marangell L.B. et al. Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study // Biol Psychiatry. − 2005. − Vol. 58 (5). − P. 355−363.
  • 134. Rush A.J., Thase M.E. Psychotherapies for depressive disorders // WPA Series. Evidence and Experience in Psychiatry. Vol. 1. Depressive Disorders / eds. M. Maj. and N. Sartorius. − Chichester, UK: John Wiley & Sons, Ltd. 1999. − P. 161−206.
  • 135. Sackeim H.A., Prudic J., Devanand D.P. et al. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities // Arch Gen Psychiatry. − 2000. − Vol. 57, No 5. − P. 425−434.
  • 136. Sartorius N., Baghai T.C., Baldwin D.S., et al. Antidepressant medications and other treatment of depressive disorders: a cinp task based on review of evidence // The International Journal of Neuropsychopharmacology. − 2007. − Vol. 10, No 1. − P. 1−207.
  • 137. Shiozawa P., Fregni F., Benseñor I.M. et al. Transcranial direct current stimulation for major depression: an updated systematic review and meta-analysis // Int J Neuropsychopharmacol. − 2014. − Vol. 17. − P. 1443–1452.
  • 138. Segal Z.V., Kennedy S.H., Cohen N.L. Clinical guidelines for the treatment of depressive disorders. V. Combining psychotherapy and pharmacotherapy // Can J Psychiatry. − 2001. − Vol. 46, Suppl. 1. − P. 59−62.
  • 139. Schlaepfer T.E., Cohen M.X., Frick C. et al. Deep brain stimulation to reward circuitry alleviates anhedonia in refractorymajor depression // Neuropsychopharmacology. – 2008. − Vol. 33, No 2. − P. 368−377.
  • 140. Tortella G., Casati R., Aparicio L. et al. Transcranial direct current stimulation in psychiatric disorders // World J Psychiatry. − 2015. − Vol. 5 (1). − P. 88–102.
  • 141. Su K.P., Huang S.Y., Chiu C.C. et al. Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial // Eur Neuropsychopharmacol. − 2003. − Vol. 13 (4). − P. 267−271/
  • 142. Trivedi M.H., Fava M., Wisniewski S.R. et al. Medication augmentation after the failure of SSRIs for depression // N Engl J Med. − 2006. − Vol. 354, No 12. − P. 1243−1252.
  • 143. Trivedi M.H., Rush A.J., Crismon M.L. et al. Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project // Arch Gen Psychiatry. − 2004. − Vol. 61, No 7. − P. 669−680.
  • 144. Tuunainen A., Kripke D.F., Endo T. Light therapy for non-seasonal depression // Cochrane Database Syst Rev. − 2004. − Vol. 2. − CD004050.
  • 145. Vos T., Flaxman A.D., Naghavi M., Lozano R., Michaud C., Ezzati M. et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990−2010: a systematic analysis for the Global Burden of Disease Study 2010 // Lancet. − 2013. − Vol. 380, No 9859. − P. 2163−2196.
  • 146. WHO. World Health Organization The global burden of disease: 2004 update.
  • 147. Wijkstra J., Burger H., van den Broek W.W. et al. Treatment of unipolar psychotic depression: a randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine // Acta Psychiatr Scand. − 2010. − Vol. 121, No 3. − P. 190−200.
  • 148. Wirz-Justice A., Van den Hoofdakker R.H. Sleep deprivation in depression: what do we know, where do we go? // Biol Psychiatry. − 1999. − Vol. 46, No 4. − P. 445−453.
  • 149. Zullino D., Baumann P. Lithium augmentation in depressive patients not responding to selective serotonin reuptake inhibitors // Pharmacopsychiatry. − 2001. − Vol. 34, No 4. − P. 119−127.